Published guidance, NICE advice and quality standards | Guidance

Showing 51 to 60 of 2013

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Alcohol-mediated perivascular renal sympathetic denervation for resistant hypertension	HTG741	11 March 2025	11 March 2025
Alcohol-use disorders: diagnosis and management of physical complications	CG100	2 June 2010	12 April 2017
Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence	CG115	23 February 2011	21 October 2014
Alcohol-use disorders: prevention	PH24	2 June 2010	2 June 2010
Alectinib for adjuvant treatment of ALK-positive non-small-cell lung cancer	TA1014	13 November 2024	13 November 2024
Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal)	TA438	29 March 2017	29 March 2017
Alectinib for untreated ALK-positive advanced non-small-cell lung cancer	TA536	8 August 2018	8 August 2018
Alemtuzumab for treating highly active relapsing–remitting multiple sclerosis	TA312	28 May 2014	21 May 2024
Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia	TA393	22 June 2016	22 June 2016
Alitretinoin for the treatment of severe chronic hand eczema	TA177	26 August 2009	26 August 2009